Non-alcoholic fatty liver disease screening in type 2 diabetes mellitus: A cost-effectiveness and price threshold analysis

Introduction: The cost-effectiveness of screening asymptomatic non-alcoholic fatty liver disease (NAFLD) patients remains debatable, with current studies assuming lifelong benefits of NAFLD screening while neglecting cardiovascular outcomes. This study aims to assess the cost-effectiveness of NAFLD...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the Academy of Medicine, Singapore Singapore, 2022-11, Vol.51 (11), p.686-694
Hauptverfasser:	Choo, Bryan Peide, Goh, George Boon-Bee, Chia, Sing Yi, Oh, Hong Choon, Tan, Ngiap Chuan, Tan, Jessica Yi Lyn, Ang, Tiing Leong, Bee, Yong Mong, Wong, Yu Jun
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!